Search clinical trials for: Relapsed/Refractory High-Risk Neuroblastoma

Total 739 results

Guangzhou Women and Children's Medical Center

Not yet recruiting

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

Neuroblastoma | GD2 Antibody | Autologous NK Cell
Guangzhou Women and Children's Medical Center

Recruiting

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

Neuroblastoma | GD2 Antibody (Naxitamab)

China
Malcolm Brenner
Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College...

Completed

Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy (CYCHE2)

Neuroblastoma

United States
Sichuan University

Recruiting

Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma (NB)

China
Chang Gung Memorial Hospital
National Taiwan University Hospital

Not yet recruiting

Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma

High Risk Neuroblastoma

Taiwan

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe